Profiling of Driver Mutations Identified Rare Compound Mutations Sensitive to Second-generation EGFR-TKI in Lung Adenocarcinoma Patients
Jun Li(Sun Yat-sen University), Hongle Li(Shanghai Jiao Tong University), Junnan Feng(Zhengzhou University), Klaas Kok(University Medical Center Groningen), Jie Ma(Zhengzhou University), Sile Han(Zhengzhou University), Yuping Guan(Zhengzhou University), Yongjun Guo(Zhengzhou University), Harry J.M. Groen(University Medical Center Groningen), Bing Wei(Henan University of Engineering), Jiawen Zheng(Zhengzhou University), Shasha Li(Harvard University), Yi Li(Zhengzhou Central Hospital), Pengfei Ren(Zhengzhou University), Cuiyun Zhang(Zhengzhou University), Ruijuan Ma(Jiangsu Academy of Agricultural Sciences), Anke van den Berg(University Medical Center Groningen)
Cited by 0
Related Papers
MEK inhibitors for the treatment of non-small cell lung cancer
|Journal of Hematology & Oncology|2021|300
SETD2: an epigenetic modifier with tumor suppressor functionality
|Oncotarget|2016|167
Visual network alterations in brain functional connectivity in chronic low back pain: A resting state functional connectivity and machine learning study
|NeuroImage Clinical|2019|117
LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis
|Biomedicine & Pharmacotherapy|2019|72